Morgan Rouprêt is 48-year-old and is currently full Professor (academic position) at APHP Sorbonne University, in the Academic Urology Department of the Pitié-Salpétrière Hospital, in Paris, France. In his daily practice, he is particularly involved in the field of onco-urology and practices mini-invasive surgery and robot-assisted laparoscopic procedures. In 1999, he received his first recognition from the Paris School of Medicine and the urology prize in 2004 from the French National Academy of Medicine. The following year, 2005, he received the gold medal AP-HP Prize and the Le Dentu-Renon Prize bestowed by the French National Academy of Surgery. In 2006, Rouprêt collected the Prize Auquier and the “Young talent” award in 2013. In addition, he received the 1st prize for the best European Urological Scolarship Programme (EUSP) from the EAU. In 2007, he won the prize for the Best Paper published on Clinical Research during the 23rd Annual EAU Congress in Milan. In 2011, he won the Hans-Marberger award from the EAU scientific office in Vienna for the best publication in a European Journal on minimally invasive surgery. Lastly, he also won the first Prize at the European Urological Award for the best challenger at the European Urology Forum in Davos. In 2015 he was the recipient of the Crystal Matula Award which is the most prestigious prize granted to a young promising European urological academician. From 2007, he has been working in the national group of experts involved in the French national guidelines. In 2008, he has been incorporated in the urothelium group of the EAU guideline office and he is involved specifically in the non muscle invasive bladder cancer group. In 2011, he also proposed renewed European Guidelines on upper urinary tract tumours. From 2007, he has been working in the national group of experts involved in the French national guidelines (AFU). From 2019, he has been appointed as chairman of the European Section of Onco-Urology (ESOU) of the EAU. Rouprêt is also a committed researcher and writer with a string of publications (i.e., 936 so far) in international, peer-reviewed journals. He focuses and writes on urological cancers particularly upper urinary tract tumours and prostate cancer. From 2023, he became the Editor-in-Chief of European Urology Oncology (Elsevier). Besides, he owns a PhD in the field of onco-urology and genetic markers. In addition, Rouprêt is the main author or co-author of several books for medical students dedicated to education in the field of urology.